These data suggest that the introduction of the multiple myeloma-associated amino acid change could impact the binding interface between EXOSC2 and MTR4, potentially impairing the function of the essential RNA exosome in vivo for a subset of Mtr4-dependent targets. This evidence concerns the gene EXOSC2 and plasma cell myeloma.